Concord Biotech (NSE:CONCORDBIO) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CONCORDBIO Concord Biotech Ltd NSE:CONCORDBIO
89 GF Score
Price ₹1,571.30
GF Value ₹1,681.38
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Concord Biotech Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:CONCORDBIO vs VRTX, REGN, RVMD: Short Percentage of Float Comparison

For the Biotechnology subindustry, Concord Biotech's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Biotech Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Concord Biotech's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Concord Biotech's Short Percentage of Float falls into.


NSE:CONCORDBIO
89GF Score
Concord Biotech Ltd NSE:CONCORDBIO
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Concord Biotech (NSE:CONCORDBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Biotech stock appears to be undervalued. The current stock price of ₹1,571.30 is trading 6.5% below its estimated GF Value™ of ₹1,681.38. GuruFocus considers Concord Biotech to be Fairly Valued.

Key valuation signals for NSE:CONCORDBIO:

  • Short Percentage of Float:
  • GF Value™: ₹1,681.38 vs. price of ₹1,571.30 (6.5% below fair value)
  • GF Score™: 89/100 with 6 warning signs

No single metric tells the full story. See the NSE:CONCORDBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Concord Biotech Business Description

Other Exchanges 543960:India
Address Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products. Geographically Company operates in two segments within India and outside India, having majority revenue from India.
89GF Score

Get the complete analysis for NSE:CONCORDBIO

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,571.30
Price
₹1,681.38
GF Value